xylometazoline has been researched along with Rosacea in 1 studies
xylometazoline: RN given refers to parent cpd; structure
Rosacea: A cutaneous disorder primarily of convexities of the central part of the FACE, such as FOREHEAD; CHEEK; NOSE; and CHIN. It is characterized by FLUSHING; ERYTHEMA; EDEMA; RHINOPHYMA; papules; and ocular symptoms. It may occur at any age but typically after age 30. There are various subtypes of rosacea: erythematotelangiectatic, papulopustular, phymatous, and ocular (National Rosacea Society's Expert Committee on the Classification and Staging of Rosacea, J Am Acad Dermatol 2002; 46:584-7).
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 1 (100.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Kim, JH | 1 |
| Oh, YS | 1 |
| Ji, JH | 1 |
| Bak, H | 1 |
| Ahn, SK | 1 |
1 other study available for xylometazoline and Rosacea
| Article | Year |
|---|---|
Rosacea (erythematotelangiectatic type) effectively improved by topical xylometazoline.
Topics: Administration, Topical; Dermatologic Agents; Facial Dermatoses; Female; Humans; Imidazoles; Middle | 2011 |